MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simasko, S. M.
Right arrow Articles by Weiland, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simasko, S. M.
Right arrow Articles by Weiland, G. A.

Two components of carbamylcholine-induced loss of nicotinic acetylcholine receptor function in the neuronal cell line PC12

SM Simasko, JR Soares and GA Weiland

Loss of responsiveness of the neuronal-type nicotinic acetylcholine receptor (nAChR) on PC12 cells, a cell line derived from a rat pheochromocytoma, was induced by exposure to carbamylcholine (carbachol). Nicotinic receptor function was assessed by carbachol- induced 22Na+ uptake. We found that, in addition to classically described desensitization, a second process occurs which results in a nonrecoverable loss of nAChR activity. This second process, which we have labeled inactivation, has a slower onset than the classically described desensitization (t1/2 = 14.7 min for inactivation and 0.78 min for desensitization at 1 mM carbachol). Inactivation could not be explained by inadequate washing, a loss of electrochemical driving force, or a loss of cell viability. The onset of inactivation is dependent on the concentration of desensitizing ligand and is blocked by nicotinic antagonists. No recovery of the loss of activity from inactivation was observed even after 2 hr of incubation in recovery buffer. Inactivation does not appear to require formation of a desensitized state since desensitization was reduced in the absence of Ca2+ whereas inactivation was not affected by the absence of Ca2+. The mechanism which underlies inactivation remains to be determined; however, it is possible that inactivation is the first step in nAChR down-regulation and it may also explain previous observations of rapid and prolonged tolerance to the effects of nicotinic agonists.

Volume 30, Issue 1, pp. 6-12, 07/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
E. L. Meyer, Y. Xiao, and K. J. Kellar
Agonist Regulation of Rat alpha 3beta 4 Nicotinic Acetylcholine Receptors Stably Expressed in Human Embryonic Kidney 293 Cells
Mol. Pharmacol., September 1, 2001; 60(3): 568 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. E. Waggoner, K. A. Dickinson, D. S. Poole, Y. Tabuse, J. Miwa, and W. R. Schafer
Long-Term Nicotine Adaptation in Caenorhabditis elegans Involves PKC-Dependent Changes in Nicotinic Receptor Abundance
J. Neurosci., December 1, 2000; 20(23): 8802 - 8811.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Mahata, M. Mahata, R. J. Parmer, and D. T. O'Connor
Desensitization of Catecholamine Release. THE NOVEL CATECHOLAMINE RELEASE-INHIBITORY PEPTIDE CATESTATIN (CHROMOGRANIN A344-364) ACTS AT THE RECEPTOR TO PREVENT NICOTINIC CHOLINERGIC TOLERANCE
J. Biol. Chem., January 29, 1999; 274(5): 2920 - 2928.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Eilers, E. Schaeffer, P. E. Bickler, and J. R. Forsayeth
Functional Deactivation of the Major Neuronal Nicotinic Receptor Caused by Nicotine and a Protein Kinase C-Dependent Mechanism
Mol. Pharmacol., December 1, 1997; 52(6): 1105 - 1112.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics